Failure of NAMPT inactivation is also explained by the presence of alternative sources of NAD+ with the nicotinate phosphoribosyltransferase (NAPRT), which catalyzes the first step of NAD+ biosynthesis from nicotinic acid (the Preiss–Handler pathway), frequently active in cancer cells. This evidence concerns the gene NAPRT and cancer.